Synovus Financial Corp. - Preferred Stock
US ˙ NYSE ˙ US87161C6003

Introduction

This page provides a comprehensive analysis of the known insider trading history of Eli Samaha. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Eli Samaha has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:STGW / Stagwell Inc. Director 134,281
US:TBPH / Theravance Biopharma, Inc. 10% Owner 9,511,150
US:SNV.PRD / Synovus Financial Corp. - Preferred Stock 10% Owner 1,293,259
US:PFSW / PFSWEB Inc 10% Owner 2,633,189
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Eli Samaha. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases SNV.PRD / Synovus Financial Corp. - Preferred Stock - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in SNV.PRD / Synovus Financial Corp. - Preferred Stock. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SNV.PRD / Synovus Financial Corp. - Preferred Stock Insider Trades
Insider Sales SNV.PRD / Synovus Financial Corp. - Preferred Stock - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in SNV.PRD / Synovus Financial Corp. - Preferred Stock. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

SNV.PRD / Synovus Financial Corp. - Preferred Stock Insider Trades
Insider Purchases STGW / Stagwell Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in SNV.PRD / Synovus Financial Corp. - Preferred Stock. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-06-05 STGW Samaha Eli 240,000 4.4300 240,000 4.4300 1,063,200 74 5.7600 319,200 30.02
2025-06-04 STGW Samaha Eli 425,757 4.2700 425,757 4.2700 1,817,982
2025-05-09 STGW Samaha Eli 200,903 4.7601 200,903 4.7601 956,318
2023-03-10 STGW Samaha Eli 750,000 6.7500 750,000 6.7500 5,062,500
2022-05-12 STGW Samaha Eli 50,000 6.8958 50,000 6.8958 344,790
2022-05-11 STGW Samaha Eli 556,846 6.9125 556,846 6.9125 3,849,198
2022-05-10 STGW Samaha Eli 37,606 6.7928 37,606 6.7928 255,450
2021-12-06 STGW Samaha Eli 290,296 8.1400 290,296 8.1400 2,363,009
2021-12-03 STGW Samaha Eli 2,665 7.8500 2,665 7.8500 20,920
2021-12-02 STGW Samaha Eli 115,000 7.7300 115,000 7.7300 888,950
2021-12-01 STGW Samaha Eli 230,400 7.6900 230,400 7.6900 1,771,776
2021-11-30 STGW Samaha Eli 104,600 7.4900 104,600 7.4900 783,454

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

STGW / Stagwell Inc. Insider Trades
Insider Sales STGW / Stagwell Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in SNV.PRD / Synovus Financial Corp. - Preferred Stock. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

STGW / Stagwell Inc. Insider Trades
Insider Purchases TBPH / Theravance Biopharma, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in SNV.PRD / Synovus Financial Corp. - Preferred Stock. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2024-08-07 tbph Samaha Eli 999,800 7.8000 999,800 7.8000 7,798,440 343 11.6500 3,849,230 49.36
2024-05-01 TBPH Samaha Eli 999,800 8.7500 999,800 8.7500 8,748,250
2024-05-01 TBPH Samaha Eli 499,324 8.7500 499,324 8.7500 4,369,085

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TBPH / Theravance Biopharma, Inc. Insider Trades
Insider Sales TBPH / Theravance Biopharma, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in SNV.PRD / Synovus Financial Corp. - Preferred Stock. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TBPH / Theravance Biopharma, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Eli Samaha as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-07-01 2025-07-01 4 STGW Stagwell Inc
Class A Common Stock
A - Award 4,444 134,281 3.42 4.50 19,998 604,264
2025-06-16 2025-06-12 4 STGW Stagwell Inc
Class A Common Stock
A - Award 30,000 129,837 30.05
2025-06-06 2025-06-05 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 240,000 8,014,322 3.09 4.43 1,063,200 35,503,446
2025-06-06 2025-06-04 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 425,757 7,774,322 5.79 4.27 1,817,982 33,196,355
2025-05-13 2025-05-09 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 200,903 7,348,565 2.81 4.76 956,318 34,979,904
2025-04-02 2025-04-01 4 STGW Stagwell Inc
Class A Common Stock
A - Award 3,305 99,837 3.42 6.05 19,995 604,014
2025-01-10 2025-01-02 4 STGW Stagwell Inc
Class A Common Stock
A - Award 3,040 96,532 3.25 6.58 20,003 635,181
2024-10-03 2024-10-01 4 STGW Stagwell Inc
Class A Common Stock
A - Award 2,849 93,492 3.14 7.02 20,000 656,314
2024-08-09 2024-08-07 4 tbph Theravance Biopharma, Inc.
COM
P - Purchase 999,800 9,511,150 11.75 7.80 7,798,440 74,186,970
2024-07-03 2024-07-01 4 STGW Stagwell Inc
Class A Common Stock
A - Award 2,933 90,643 3.34 6.82 20,003 618,185
2024-06-14 2024-06-12 4 STGW Stagwell Inc
Class A Common Stock
A - Award 22,762 87,710 35.05
2024-06-11 2024-06-10 4 SNV PR E SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
S - Sale -172,889 1,293,259 -11.79 25.20 -4,357,321 32,594,007
2024-06-07 2024-06-07 4 SNV PR E SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
S - Sale -20 1,466,148 0.00 25.20 -504 36,946,930
2024-06-07 2024-06-06 4 SNV PR E SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
S - Sale -325 1,466,168 -0.02 25.24 -8,203 37,004,321
2024-06-07 2024-06-05 4 SNV PR E SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
S - Sale -6,803 1,466,493 -0.46 25.22 -171,544 36,979,087
2024-06-04 2024-06-04 4 SNV PR E SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
S - Sale -6,278 1,473,296 -0.42 25.23 -158,395 37,171,553
2024-06-04 2024-06-03 4 SNV PR E SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
S - Sale -13,685 1,479,574 -0.92 25.23 -345,325 37,335,274
2024-06-04 2024-05-31 4 SNV PR E SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
S - Sale -200,000 1,493,259 -11.81 25.07 -5,014,900 37,442,723
2024-05-03 2024-05-01 4 TBPH Theravance Biopharma, Inc.
COM
P - Purchase 499,324 8,511,350 6.23 8.75 4,369,085 74,474,312
2024-05-03 2024-05-01 4 TBPH Theravance Biopharma, Inc.
COM
P - Purchase 999,800 8,012,026 14.26 8.75 8,748,250 70,105,228
2023-10-24 2023-10-20 4 SNV PRE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 560 1,693,259 0.03 21.35 11,956 36,151,080
2023-10-16 2023-10-13 4 SNV PRE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 4,279 1,692,699 0.25 21.50 91,998 36,393,028
2023-10-16 2023-10-12 4 SNV PRE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 235 1,688,420 0.01 21.50 5,052 36,301,030
2023-10-11 2023-10-11 4 SNV PRE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 881 1,688,185 0.05 21.50 18,942 36,295,978
2023-10-11 2023-10-10 4 SNV PRE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 1,072 1,687,304 0.06 21.50 23,048 36,277,036
2023-10-11 2023-10-09 4 SNV PRE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 957 1,686,232 0.06 21.15 20,241 35,663,807
2023-10-04 2023-10-02 4 SNV PRE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 3,466 1,685,275 0.21 21.28 73,756 35,862,652
2023-09-28 2023-09-27 4 SNV PRE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 12,196 1,681,809 0.73 21.30 259,775 35,822,532
2023-09-26 2023-09-26 4 SNV PRE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 9,633 1,669,613 0.58 21.30 205,183 35,562,757
2023-09-26 2023-09-25 4 SNV PRE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 7,553 1,659,980 0.46 21.30 160,879 35,357,574
2023-09-26 2023-09-22 4 SNV PRE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 9,036 1,652,427 0.55 21.30 192,467 35,196,695
2023-09-21 2023-09-21 4 SNV PrE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 8,884 1,643,391 0.54 21.25 188,789 34,922,716
2023-09-21 2023-09-20 4 SNV PrE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 36,425 1,634,507 2.28 21.40 779,495 34,978,450
2023-09-21 2023-09-19 4 SNV PrE SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
P - Purchase 197,705 1,598,082 14.12 21.40 4,230,333 34,194,480
2023-08-18 3 SNV PR E SYNOVUS FINANCIAL CORP
Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series E
1,400,377
2023-06-16 2023-06-14 4 STGW Stagwell Inc
Class A Common Stock
A - Award 18,940 64,948 41.17
2023-03-14 2023-03-10 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 750,000 7,147,662 11.72 6.75 5,062,500 48,246,718
2022-12-30 2022-12-29 4 PFSW PFSWEB INC
Common Stock
P - Purchase 883,000 2,633,189 50.45 6.00 5,298,000 15,799,134
2022-12-30 2022-12-29 4 PFSW PFSWEB INC
Common Stock
S - Sale -883,000 1,750,189 -33.53 6.00 -5,298,000 10,501,134
2022-12-30 2022-12-28 4 PFSW PFSWEB INC
Common Stock
P - Purchase 1,750,000 2,633,189 198.15 5.92 10,360,000 15,588,479
2022-12-30 2022-12-28 4 PFSW PFSWEB INC
Common Stock
S - Sale -1,750,000 883,189 -66.46 5.92 -10,360,000 5,228,479
2022-10-21 3 tbph Theravance Biopharma, Inc.
COM
7,012,226
2022-06-28 2022-06-24 4 PFSW PFSWEB INC
Common Stock
P - Purchase 23,448 2,633,189 0.90 11.72 274,811 30,860,975
2022-06-17 2022-04-15 4 PFSW PFSWEB INC
Common Stock
P - Purchase 6,200 2,609,741 0.24 12.00 74,400 31,316,892
2022-06-17 2022-04-14 4 PFSW PFSWEB INC
Common Stock
P - Purchase 7,307 2,603,541 0.28 11.62 84,907 30,253,146
2022-06-16 2022-06-14 4 STGW Stagwell Inc
Class A Common Stock
A - Award 21,008 46,008 84.03
2022-05-12 2022-05-12 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 50,000 6,397,662 0.79 6.90 344,790 44,116,998
2022-05-12 2022-05-11 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 556,846 6,347,662 9.62 6.91 3,849,198 43,878,214
2022-05-12 2022-05-10 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 37,606 5,790,816 0.65 6.79 255,450 39,335,855
2022-04-29 2022-04-29 4 PFSW PFSWEB INC
Common Stock
P - Purchase 2,000 2,596,234 0.08 11.24 22,480 29,181,670
2022-04-29 2022-04-28 4 PFSW PFSWEB INC
Common Stock
P - Purchase 40,103 2,594,234 1.57 11.25 451,159 29,185,132
2022-04-29 2022-04-27 4 PFSW PFSWEB INC
Common Stock
P - Purchase 21,087 2,554,131 0.83 11.19 235,964 28,580,726
2022-04-26 2022-04-26 4 PFSW PFSWEB INC
Common Stock
P - Purchase 35,934 2,533,044 1.44 11.13 399,945 28,192,780
2022-04-26 2022-04-25 4 PFSW PFSWEB INC
Common Stock
P - Purchase 13,735 2,497,110 0.55 11.18 153,557 27,917,690
2022-04-26 2022-04-22 4 PFSW PFSWEB INC
Common Stock
P - Purchase 35,931 2,461,179 1.48 11.15 400,631 27,442,146
2022-04-21 3 PFSW PFSWEB INC
Common Stock
2,447,444
2021-12-07 2021-12-06 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 290,296 5,753,210 5.31 8.14 2,363,009 46,831,129
2021-12-07 2021-12-03 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 2,665 5,462,914 0.05 7.85 20,920 42,883,875
2021-12-02 2021-12-02 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 115,000 5,460,249 2.15 7.73 888,950 42,207,725
2021-12-02 2021-12-01 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 230,400 5,345,249 4.50 7.69 1,771,776 41,104,965
2021-12-02 2021-11-30 4 STGW Stagwell Inc
Class A Common Stock
P - Purchase 104,600 5,114,849 2.09 7.49 783,454 38,310,219
2021-08-11 3 STGW Stagwell Inc
Class A Common Stock
5,010,249
2021-08-11 2021-08-09 4 STGW Stagwell Inc
Class A Common Stock
A - Award 25,000 25,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)